Is CBD really the panacea?

The relationship in between infection and conventional antibiotics

Could CBD be useful in the battle versus resistant bacterial pressures? The arise from the University of Queensland in Australia recommend that it is possible. However before analyzing the research study in depth, it works to understand the evolution of the relationship in between germs and antibiotics.

Because the innovative discovery of penicillin by Alexander Fleming in 1928, antibiotics have actually been an important tool in the battle versus germs and infections. And although we still utilize the same proven methods today, germs have actually progressed. When exposed to antibiotics, particular germs, fungi and parasites are able to adapt and cancel the efficiency of the drug by developing resistance.

It’s worth mentioning that antimicrobial resistance was most likely to happen anyhow, as the genetic code for germs modifications over time. However, it is believed that the overuse of antibiotics is an important factor that speeds up the advancement of resistant pressures.

According to the World Health Organization, antimicrobial resistance “is a significantly serious threat to global public health that requires action in all sectors of government and in society.” This has actually led researchers to believe outside package by attempting to recognize compounds that could be helpful in the battle versus damaging germs. One of these compounds is cannabidiol (CBD), a cannabinoid discovered in Cannabis sativa.

Researchers are searching for brand-new methods to attack infections and resistant germs.

Dr. Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery and Senior Research Officer at the Institute for Molecular Bioscience at the University of Queensland, concluded that CBD is effective versus Gram-positive germs. Strains of Gram-positive germs include Staphylococcus aureus (common in skin infections) and Streptococcus pneumoniae (common in bacterial pneumonia).

Dr. Blaskovich provided his findings at an annual meeting of the American Society for Microbiology. In vitro samples of both types of gram-positive germs were treated with artificial CBD. The results led Dr. Blaskovich to the conclusion that CBD operates at levels similar to those of prescription antibiotics vancomycin and daptomycin. He also found that CBD appeared to work against gram-positive pressures of resistant germs, which lots of standard antibiotics are starting to stop working.

” In specific, the activity was chosen versus the resistant pressures of Staphylococcus aureus (MRSA, VISA, SARV), Streptococcus pneumoniae (MDR), and Enterococcus faecalis (ERV). Cannabidiol was bactericidal, had a low tendency to cause resistance and was active versus MRSA biofilms. “

The team also performed another research study using topical CBD to deal with a skin infection in mice. Once again, although the results were positive, CBD did not appear to eliminate the infection, but merely to minimize the number of bacterial cells.

Could CBD become an antibiotic?

While it is easy to hail this work as a substantial breakthrough in the anti-bacterial capabilities of CBD, it is prematurely to give up on penicillin.

Although it is believed that the efficiency of component CBD might originate from the method it attacks the biofilm surrounding bacterial cells, the authors are still unsure of the mechanism of action of CBD. They also did not hesitate to point out the drawbacks of the research study. Dr. Blaskovich pointed out that given that the results are in the initial stages, it is far prematurely for individuals to begin treating their CBD infections themselves.

The research study was also performed in vitro (outside the body), and there is a danger that the results of scientific trials will not be the same. Several compounds have actually shown anti-bacterial effectiveness in petri dishes, but then stopped working at this crucial stage. It should also be discussed that the two research studies were performed in collaboration with Botanix Pharmaceuticals Ltd, a pharmaceutical business concentrating on topical CBD Flavor products.

However, this research could be an important step forward for CBD and the battle versus antimicrobial resistance. CBD continues to have a great safety profile and is not considered harmful even in big quantities. Thankfully, Dr. Blaskovich and his team strategy to continue their research.

Scroll to top